| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,746 |
1,439 |
$99K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
872 |
687 |
$60K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
97 |
76 |
$17K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
101 |
88 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
65 |
60 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
100 |
82 |
$4K |
| 87631 |
|
45 |
33 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
68 |
59 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
206 |
177 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
14 |
13 |
$1K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12 |
12 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
12 |
$328.46 |
| 86710 |
|
13 |
12 |
$250.29 |